Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)

Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Jul 25, 2024

Keywords

ClinConnect Summary

The Clinnova-MS trial is a study designed to learn more about Multiple Sclerosis (MS), a condition that affects the nervous system. Researchers want to understand how early signs of MS and changes in the disease can be identified. They will also explore new ways to monitor patients continuously using digital tools. This study is currently looking for participants who are 18 years or older, have been diagnosed with MS within the last three years, and have the ability to use a smartphone app that helps track their health.

If you decide to participate, you can expect to attend study visits where you will provide data and samples to help with the research. You'll need to be comfortable using a smartphone and have good enough vision and hand skills to do so. There are no specific exclusions, meaning most people with MS can consider joining. This trial could contribute to improving how MS is monitored and treated in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥18
• • Participants are willing and able to comply with the protocol, including undergoing data and samples collection as well as study visits and examinations.
• • Signed informed consent form
• • In possession of a Healios+Me app compatible smartphone (iOS/Android)
• • Corrected close visual acuity of ≥0.5
• • Hand motor skills sufficient for using a smartphone
• • Ability to follow the study procedures
• • Diagnosed with MS according to the revised McDonald criteria 2017, all clinical forms inclusive (clinically isolated syndrome, RRMS, SPMS, PPMS) AND early disease stages (\< 3 years) OR transitioning phase to progressive disease as evaluated based on Expanded Disability Status Scale (EDSS).
• • Enrolled in the SMSC at University Hospital Basel
• • There are no specific exclusion criteria.